Try our beta test site

Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)

This study has been completed.
Information provided by:
Biogen Identifier:
First received: September 30, 2002
Last updated: September 12, 2013
Last verified: May 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: April 2004 (Final data collection date for primary outcome measure)